Literature DB >> 22680301

Toll-like receptor 2 knockdown modulates interleukin (IL)-6 and IL-8 but not stromal derived factor-1 (SDF-1/CXCL12) in human periodontal ligament and gingival fibroblasts.

Ana Carolina F Morandini1, Pedro Paulo Chaves Souza, Erivan Schnaider Ramos-Junior, Daniel Thomas Brozoski, Carla Renata Sipert, Carlos Alberto Souza Costa, Carlos Ferreira Santos.   

Abstract

BACKGROUND: Fibroblasts are now seen as active components of the immune response because these cells express Toll-like receptors (TLRs), recognize pathogen-associated molecular patterns, and mediate the production of cytokines and chemokines during inflammation. The innate host response to lipopolysaccharide (LPS) from Porphyromonas gingivalis is unusual inasmuch as different studies have reported that it can be an agonist for Toll-like receptor 2 (TLR2) and an antagonist or agonist for Toll-like receptor 4 (TLR4). This study investigates and compares whether signaling through TLR2 or TLR4 could affect the secretion of interleukin (IL)-6, IL-8, and stromal derived factor-1 (SDF-1/CXCL12) in both human gingival fibroblasts (HGF) and human periodontal ligament fibroblasts (HPDLF).
METHODS: After small interfering RNA-mediated silencing of TLR2 and TLR4, HGF and HPDLF from the same donors were stimulated with P. gingivalis LPS or with two synthetic ligands of TLR2, Pam2CSK4 and Pam3CSK4, for 6 hours. IL-6, IL-8, and CXCL12 mRNA expression and protein secretion were evaluated by quantitative polymerase chain reaction and enzyme-linked immunosorbent assay, respectively.
RESULTS: TLR2 mRNA expression was upregulated in HGF but not in HPDLF by all the stimuli applied. Knockdown of TLR2 decreased IL-6 and IL-8 in response to P. gingivalis LPS, or Pam2CSK4 and Pam3CSK4, in a similar manner in both fibroblasts subpopulations. Conversely, CXCL12 remained unchanged by TLR2 or TLR4 silencing.
CONCLUSION: These results suggest that signaling through TLR2 by gingival and periodontal ligament fibroblasts can control the secretion of IL-6 and IL-8, which contribute to periodontal pathogenesis, but do not interfere with CXCL12 levels, an important chemokine in the repair process.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22680301     DOI: 10.1902/jop.2012.120177

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  17 in total

1.  Thrombospondin-1 Production Regulates the Inflammatory Cytokine Secretion in THP-1 Cells Through NF-κB Signaling Pathway.

Authors:  Tian Xing; Yao Wang; Wen-Jie Ding; Yuan-Ling Li; Xiao-Dong Hu; Cong Wang; Ao Ding; Ji-Long Shen
Journal:  Inflammation       Date:  2017-10       Impact factor: 4.092

2.  Effects of PBM in different energy densities and irradiance on maintaining cell viability and proliferation of pulp fibroblasts from human primary teeth.

Authors:  Nádia Carolina Teixeira Marques; Natalino Lourenço Neto; Mariel Tavares Oliveira Prado; Luciana Lourenço Ribeiro Vitor; Rodrigo Cardoso Oliveira; Vivien Thiemy Sakai; Carlos Ferreira Santos; Maria Aparecida Andrade Moreira Machado; Thais Marchini Oliveira
Journal:  Lasers Med Sci       Date:  2017-08-11       Impact factor: 3.161

3.  In vitro regulation of CCL3 and CXCL12 by bacterial by-products is dependent on site of origin of human oral fibroblasts.

Authors:  Carla Renata Sipert; Ana Carolina Morandini; Thiago José Dionísio; Maria Aparecida Andrade Moreira Machado; Sandra Helena Penha Oliveira; Ana Paula Campanelli; Winston Patrick Kuo; Carlos Ferreira Santos
Journal:  J Endod       Date:  2013-10-27       Impact factor: 4.171

4.  The negative feedback regulation of microRNA-146a in human periodontal ligament cells after Porphyromonas gingivalis lipopolysaccharide stimulation.

Authors:  Shao-Yun Jiang; Dong Xue; Yu-Feng Xie; Dong-Wang Zhu; Yun-Yun Dong; Cong-Cong Wei; Jia-Yin Deng
Journal:  Inflamm Res       Date:  2015-05-07       Impact factor: 4.575

5.  Beyond toll-like receptors: Porphyromonas gingivalis induces IL-6, IL-8, and VCAM-1 expression through NOD-mediated NF-κB and ERK signaling pathways in periodontal fibroblasts.

Authors:  Jianru Liu; Yixiang Wang; Xiangying Ouyang
Journal:  Inflammation       Date:  2014-04       Impact factor: 4.092

6.  Tetra- and penta-acylated lipid A structures of Porphyromonas gingivalis LPS differentially activate TLR4-mediated NF-κB signal transduction cascade and immuno-inflammatory response in human gingival fibroblasts.

Authors:  Thanuja D K Herath; Richard P Darveau; Chaminda J Seneviratne; Cun-Yu Wang; Yu Wang; Lijian Jin
Journal:  PLoS One       Date:  2013-03-12       Impact factor: 3.240

7.  CCL3 and CXCL12 production in vitro by dental pulp fibroblasts from permanent and deciduous teeth stimulated by Porphyromonas gingivalis LPS.

Authors:  Carla Renata Sipert; Ana Carolina de Faria Morandini; Karin Cristina da Silva Modena; Thiago José Dionísio; Maria Aparecida Andrade Moreira Machado; Sandra Helena Penha de Oliveira; Ana Paula Campanelli; Carlos Ferreira Santos
Journal:  J Appl Oral Sci       Date:  2013 Mar-Apr       Impact factor: 2.698

8.  Palatal mucosa derived fibroblasts present an adaptive behavior regarding cytokine secretion when grafted onto the gingival margin.

Authors:  Fabíola Pontes Azevedo; Ana Carolina Faria Morandini; Carla Renata Sipert; Thiago José Dionísio; Carlos Ferreira Santos; Carla Andreotti Damante; Maria Lúcia Rubo de Rezende; Adriana Campos Passanezi Sant'ana; Sebastião Luiz Aguiar Greghi
Journal:  BMC Oral Health       Date:  2014-03-20       Impact factor: 2.757

9.  Endocannabinoids and inflammatory response in periodontal ligament cells.

Authors:  Burcu Özdemir; Bin Shi; Hans Peter Bantleon; Andreas Moritz; Xiaohui Rausch-Fan; Oleh Andrukhov
Journal:  PLoS One       Date:  2014-09-16       Impact factor: 3.240

10.  Leptin and Pro-Inflammatory Stimuli Synergistically Upregulate MMP-1 and MMP-3 Secretion in Human Gingival Fibroblasts.

Authors:  Rachel C Williams; Andrew J Skelton; Stephen M Todryk; Andrew D Rowan; Philip M Preshaw; John J Taylor
Journal:  PLoS One       Date:  2016-02-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.